Member Name: Stephen Boatwright
Company: Gallagher & Kennedy
Steve Boatwright has represented diverse private and public companies in all industry sectors. Mr. Boatwright’s practice focuses on representing start-up, emerging growth and public companies in various fields such as technology, biotechnology, internet, life science and medical devices for their securities, corporate, licensing and intellectual property needs both domestically and internationally.
Negotiated/documented over $1 billion in financings/mergers/ acquisitions;
Prepared registration statements for over 20 different public companies trading on NYSE/AMEX, NASDAQ and the OTCBB;
Developed the strategy and represented the company which took Smith & Wesson Corporation public immediately prior to its 150 year anniversary;
Represented the company with the fifth highest share price increase on any NYSE market in 2014;
Prepared private placement memoranda for technology, biotechnology, life science, medical device, internet, social media, restaurant and real estate companies raising in excess of $200 million; and
Over 25 years of experience in “shell” reverse merger transactions.
Not only has he represented corporations, but angel investors, investment banking, private equity, venture capital and venture leasing funds have also relied on his expertise to structure their funds and acquire substantial positions in emerging growth companies.
In addition to businesses, Mr. Boatwright has represented numerous real estate concerns assisting with their securities issues and was a member of the team of attorneys which filed one of the first registration statements for commercial mortgage backed securities with the SEC.